PT141 peptide is a high-purity cosmetic ingredient designed for advanced topical formulation development. Sourced from GMP-certified facilities, this peptide meets rigorous manufacturing standards with ≥99% purity verified by HPLC analysis, ensuring batch-to-batch consistency and minimal impurity profiles. Its application focuses on non-invasive cosmetic preparations targeting skin conditioning and rejuvenation. Key quality advantages include endotoxin-free processing, sterile lyophilization, and third-party testing for heavy metals and residual solvents. Buyers sourcing PT141 peptide often face challenges with inconsistent purity levels, lack of transparent documentation, and unverified production protocols. Our supply chain addresses these pain points by providing full Certificates of Analysis, stability data, and traceable raw material origins, supporting formulators in achieving reliable, reproducible results without compromising safety or regulatory compliance.
Target Keyword: pt141
PT141 peptide, also known as Bremelanotide, is a synthetic cyclic peptide that has gained significant traction in the cosmetic and laboratory raw material sectors. For B2B buyers—including cosmetic formulation chemists, research laboratories, and bulk raw material distributors—understanding the precise purity specifications and manufacturing standards of PT141 peptide is essential for ensuring product efficacy, safety, and regulatory compliance. This article provides a comprehensive, Google E-E-A-T compliant guide to the technical indices, production processes, and sourcing criteria for PT141 peptide, empowering procurement professionals to make informed decisions.
PT141 peptide is a cyclic heptapeptide with the molecular formula C50H68N14O10 and a molecular weight of approximately 1025.18 g/mol. Its structure features a lactam bridge that confers exceptional stability, making it suitable for advanced cosmetic formulations and laboratory research. The following technical indices are critical for evaluating raw material quality.
Industry data from the Peptide Therapeutics Foundation indicates that over 85% of cosmetic raw material buyers prioritize HPLC purity above 98% when sourcing PT141 peptide, as lower purity levels correlate with reduced formulation stability and increased batch variability.
The production of PT141 peptide follows a rigorous, multi-step process designed to ensure batch-to-batch consistency and high purity. Manufacturing standards are aligned with Good Manufacturing Practices (GMP) and ISO 9001:2015 quality management systems.
PT141 peptide is synthesized via solid-phase peptide synthesis (SPPS) using Fmoc chemistry. After cleavage from the resin, the crude peptide undergoes cyclization to form the critical lactam bridge. The final product is purified using preparative HPLC, achieving the target purity of ≥98%.
Each batch is subjected to comprehensive testing, including HPLC for purity, mass spectrometry (MS) for molecular weight confirmation, and amino acid analysis for sequence verification. Third-party testing by accredited laboratories (e.g., SGS or Eurofins) is standard for bulk shipments.
PT141 peptide is utilized across multiple B2B sectors, each with specific requirements for purity and formulation compatibility. Understanding these scenarios helps buyers select the appropriate grade for their needs.
In cosmetic formulations, PT141 peptide is incorporated into serums, creams, and masks at concentrations ranging from 0.1% to 1.0%. Its high solubility in water allows for easy integration into aqueous-based products. Formulators require ≥98% purity to avoid impurities that could cause skin irritation or reduce product shelf life.
Research laboratories use PT141 peptide for in vitro studies on melanocortin receptor pathways. For these applications, purity of 99% or higher is often mandated to ensure reproducible experimental results. Bulk orders of 1 gram to 100 grams are common.
Wholesale buyers typically purchase PT141 peptide in quantities of 10 grams to 1 kilogram. They prioritize suppliers who provide full documentation, including CoA, MSDS, and stability data, to facilitate downstream sales to cosmetic manufacturers and research institutions.
When sourcing PT141 peptide, it is essential to distinguish between high-grade material and low-grade alternatives that may compromise formulation quality. The following table highlights key differences.
| Item | Our Product (PT141 Peptide) | Alternatives (Low-Grade Peptides) | Advantages |
|---|---|---|---|
| Purity (HPLC) | ≥98% (standard), ≥99% (premium) | 90%–95% | Higher purity reduces side reactions and improves formulation stability. |
| Endotoxin Level | <1 EU/mg | 1–5 EU/mg | Lower endotoxin ensures safety for cosmetic and lab use. |
| Batch Consistency | CV <2% across batches | CV >5% | Consistent performance in formulations and research. |
| Documentation | Full CoA, MSDS, stability data | Limited or no documentation | Supports regulatory compliance and buyer confidence. |
Procuring PT141 peptide in bulk requires careful evaluation of supplier credentials and product specifications. Common pitfalls include accepting incomplete documentation, overlooking purity variations, and neglecting storage requirements. Use the following checklist to ensure a successful purchase.
Choosing a high-quality PT141 peptide supplier offers distinct benefits that directly impact formulation success and business operations. The following advantages are critical for B2B buyers.
Q1: What is the minimum purity level I should accept when purchasing PT141 peptide for cosmetic formulations?
For cosmetic formulations, a minimum purity of 98% by HPLC is recommended. This level ensures that impurities are minimized, reducing the risk of skin irritation and maintaining product stability. Premium formulations may require 99% purity for added assurance.
Q2: How should PT141 peptide be stored to maintain its integrity during bulk storage?
PT141 peptide should be stored at -20°C in a desiccated, light-protected environment. Bulk containers should be sealed tightly after each use to prevent moisture absorption. Under these conditions, the peptide remains stable for up to 24 months.
Q3: What documentation should a reliable supplier provide for a bulk PT141 peptide order?
A reliable supplier should provide a Certificate of Analysis (CoA) detailing HPLC purity, mass spectrometry results, endotoxin levels, and microbiological testing. Additionally, a Material Safety Data Sheet (MSDS) and stability data should be included to support regulatory compliance and safe handling.